|
|
|
40
|
0012ER
|
GLENCET 5MG TAB (GLP/ALI) LEVOCETIRIZINE
|
LEVOCETIRIZINE
|
GLENCET
|
30'S
|
C
|
6.80
|
0.23
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ALI
|
ALL HEALTH INC
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2022-03-22
|
Delete from contract
|
Oral
|
0
|
ANTIHISTAMINICS
|
2022-03-22
|
|
|
|
40
|
0012FD
|
GLENCET 5MG TAB (GLP/ATB) LEVOCETIRIZINE
|
LEVOCETIRIZINE
|
GLENCET
|
30'S
|
C
|
6.80
|
0.23
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
0
|
ANTIHISTAMINICS
|
2022-03-22
|
|
|
|
42
|
0012GR
|
FEEGRA 120MG SR TAB (JLP) FEXOFENADINE
|
FEXOFENADINE
|
FEEGRA
|
10X10
|
C
|
27.18
|
0.27
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2026-04-01
|
|
|
ORAL
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
|
|
|
|
42
|
0014U
|
JONCPM 10MG/ML IV/IM INJ (JLP) CHLORPHENIRAMINE
|
CHLORPHENIRAMINE
|
JONCPM
|
10X1ML
|
B
|
3.26
|
0.33
|
AMPG
|
30
|
AMP
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0404
|
FIRST GENERATION ANTIHISTAMINES
|
2026-04-01
|
|
|
IV/IM/SC
|
6
|
FIRST GENERATION ANTIHISTAMINES
|
|
|
|
|
42
|
0111FJ
|
XORICEF 500MG TAB (JLP) CEFUROXIME
|
CEFUROXIME
|
XORICEF
|
10X10
|
BH
|
51.65
|
0.52
|
TAB
|
20
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0114BP
|
ALTACEF 250MG TAB (GLP/ATB) CEFUROXIME
|
CEFUROXIME
|
ALTACEF
|
10'S
|
BQ
|
4.08
|
0.41
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-03-22
|
|
|
|
42
|
0114BV
|
XORICEF 250MG TAB (JLP) CEFUROXIME
|
CEFUROXIME
|
XORICEF
|
10X10
|
BQ
|
39.96
|
0.40
|
TAB
|
28
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
42
|
0225N
|
CLOXAMAX 500MG INJ (JLP) CLOXACILLIN
|
CLOXACILLIN
|
CLOXAMAX
|
500MG VIAL
|
BQ
|
5.98
|
5.98
|
VIAL
|
56
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2026-04-01
|
|
|
IV/IM
|
0
|
PENICILLINS
|
|
|
|
|
42
|
0292V
|
CLIFORD 150MG CAP (JLP) CLINDAMYCIN HCL
|
CLINDAMYCIN HCL
|
CLIFORD
|
100'S
|
A
|
21.75
|
0.22
|
CAP
|
28
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081228
|
ANTIBACTERIALS, MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIBACTERIALS, MISCELLANEOUS
|
|
|
|
|
42
|
0321BD
|
GENTACURE 40MG/ML IV/IM INJ (JLP) GENTAMICIN
|
GENTAMICIN
|
GENTACURE
|
100X2ML
|
B
|
78.83
|
0.79
|
VIAL
|
0
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081202
|
AMINOGLYCOSIDES
|
2026-04-01
|
|
|
IV/IM
|
0
|
AMINOGLYCOSIDES
|
|
|
|
|
41
|
0487B
|
METRONIDAZOLE 0.75% GEL (GLP) (C)
|
METRONIDAZOLE
|
METRONIDAZOLE
|
30G
|
C
|
26.5852
|
26.5852
|
TUBE
|
0
|
TUBE
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
CWS
|
CAPSULE WHOLESALE
|
|
0832
|
TRICHOMONACIDES
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
TRICHOMONACIDES
|
|
|
|
|
42
|
0502M
|
URIFON 100MG SR TAB (JLP) NITROFURANTOIN
|
NITROFURANTOIN
|
URIFON
|
10X10
|
A
|
15.63
|
0.16
|
TAB
|
28
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0836
|
URINARY ANTI-INFECTIVES
|
2026-04-01
|
|
|
ORAL
|
0
|
URINARY ANTI-INFECTIVES
|
|
|
|
|
42
|
0633AD
|
LEETREXATE 25MG/ML INJ (JLP) METHOTREXATE
|
METHOTREXATE
|
LEETREXATE
|
2ML VIAL
|
B
|
4.62
|
4.62
|
VIAL
|
5
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV/IM
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0702K
|
PYRIDOSTIN 60MG TAB (JLP) PYRIDOSTIGMINE
|
PYRIDOSTIGMINE
|
PYRIDOSTIN
|
10X10
|
A
|
54.37
|
0.54
|
TAB
|
180
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
42
|
0721E
|
DEFJOHN 6MG TAB (JLP) DEFLAZACORT
|
DEFLAZACORT
|
DEFJOHN
|
10X10
|
C
|
21.47
|
0.21
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
ORAL
|
0
|
ADRENALS
|
|
|
|
|
42
|
0722C
|
DEFJOHN 30MG TAB (JLP) DEFLAZACORT
|
DEFLAZACORT
|
DEFJOHN
|
10X10
|
C
|
11.15
|
0.11
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
ORAL
|
0
|
ADRENALS
|
|
|
|
|
42
|
0791AD
|
ADREFORD 1MG/ML IV/IM INJ (JLP) ADRENALINE
|
ADRENALINE
|
ADREFORD
|
100X1ML
|
B
|
32.62
|
0.33
|
AMPG
|
60
|
AMP
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2026-04-01
|
|
|
IV/IM
|
0
|
ALPHA & BETA ADRENERGIC AGONIST
|
|
|
|
|
42
|
0981AX
|
IRONFAST 200MG TAB (JLP) FERROUS SULPHATE
|
FERROUS SULPHATE
|
IRONFAST
|
200'S
|
A
|
12.50
|
0.06
|
TAB
|
90
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
200404
|
IRON PREPARATIONS
|
2026-04-01
|
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
42
|
1011BF
|
HEPAQUINT 5000U/ML INJ (JLP) HEPARIN
|
HEPARIN
|
HEPAQUINT
|
10X5ML
|
B
|
92.97
|
9.30
|
VIAL
|
6
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
20120416
|
HEPARINS
|
2026-04-01
|
|
|
IV
|
6
|
HEPARINS
|
|
|
|
|
42
|
1041B
|
PROTAXCEL 10MG/ML INJ (JLP) PROTAMINE SULPHATE
|
PROTAMINE SULPHATE
|
PROTAXCEL
|
5X5ML
|
BQ
|
40.77
|
8.15
|
AMPG
|
20
|
AMP
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202808
|
ANTIHEPARIN
|
2026-04-01
|
|
|
IV
|
0
|
ANTIHEPARIN
|
|
